title: Modulation of neonatal microbial recognition: TLR-mediated innate immune responses are specifically and differentially modulated by human milk.
abstract: The mechanisms controlling innate microbial recognition in the neonatal gut are still to be fully understood. We have sought specific regulatory mechanisms operating in human breast milk relating to TLR-mediated microbial recognition. In this study, we report a specific and differential modulatory effect of early samples (days 1-5) of breast milk on ligand-induced cell stimulation via TLRs. Although a negative modulation was exerted on TLR2 and TLR3-mediated responses, those via TLR4 and TLR5 were enhanced. This effect was observed in human adult and fetal intestinal epithelial cell lines, monocytes, dendritic cells, and PBMC as well as neonatal blood. In the latter case, milk compensated for the low capacity of neonatal plasma to support responses to LPS. Cell stimulation via the IL-1R or TNFR was not modulated by milk. This, together with the differential effect on TLR activation, suggested that the primary effect of milk is exerted upstream of signaling proximal to TLR ligand recognition. The analysis of TLR4-mediated gene expression, used as a model system, showed that milk modulated TLR-related genes differently, including those coding for signal intermediates and regulators. A proteinaceous milk component of > or =80 kDa was found to be responsible for the effect on TLR4. Notably, infant milk formulations did not reproduce the modulatory activity of breast milk. Together, these findings reveal an unrecognized function of human milk, namely, its capacity to influence neonatal microbial recognition by modulating TLR-mediated responses specifically and differentially. This in turn suggests the existence of novel mechanisms regulating TLR activation.
authors.affiliation: Infection and Immunity, Department of Medical Biochemistry and Immunology, Cardiff University College of Medicine, Heath Park, Cardiff CF14 4XX, Wales, UK.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: LeBouder
authors.forename: Julia E
authors.initials: JE
authors.lastname: Rey-Nores
authors.forename: Anne-Catherine
authors.initials: AC
authors.lastname: Raby
authors.forename: Michael
authors.initials: M
authors.lastname: Affolter
authors.forename: Karine
authors.initials: K
authors.lastname: Vidal
authors.forename: Catherine A
authors.initials: CA
authors.lastname: Thornton
authors.forename: Mario O
authors.initials: MO
authors.lastname: Labéta
mesh_terms: D002460:Cell Line; D005786:Gene Expression Regulation / Q000187:drug effects; D006434:Hemocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects / Q000276:immunology*; D041943:Infant Formula / Q000494:pharmacology; D007231:Infant, Newborn; D008070:Lipopolysaccharides / Q000494:pharmacology; D008895:Milk, Human / Q000276:immunology*; D017472:Receptors, Interleukin-1 / Q000378:metabolism; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism; D051193:Toll-Like Receptors / Q000276:immunology* / Q000378:metabolism
chemical_list: D008070:Lipopolysaccharides; D017472:Receptors, Interleukin-1; D018124:Receptors, Tumor Necrosis Factor; D051193:Toll-Like Receptors